|
VHL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.919200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.376400E-04 |
| Normal-vs-Stage2 |
2.014800E-01 |
| Normal-vs-Stage3 |
7.866300E-02 |
| Normal-vs-Stage4 |
3.966500E-02 |
| Stage1-vs-Stage2 |
5.815600E-01 |
| Stage1-vs-Stage3 |
7.475000E-01 |
| Stage1-vs-Stage4 |
4.885000E-01 |
| Stage2-vs-Stage3 |
8.257200E-01 |
| Stage2-vs-Stage4 |
3.441600E-01 |
| Stage3-vs-Stage4 |
4.185400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.959400E-03 |
| Normal-vs-AfricanAmerican |
6.683000E-03 |
| Normal-vs-Asian |
6.770800E-04 |
| Caucasian-vs-AfricanAmerican |
5.861800E-01 |
| Caucasian-vs-Asian |
2.600000E-01 |
| AfricanAmerican-vs-Asian |
3.028400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.94760000000027E-05 |
| Normal-vs-Female |
7.695400E-01 |
| Male-vs-Female |
8.804700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.117990E-02 |
| Normal-vs-Extreme_Weight |
4.11449999999647E-05 |
| Normal-vs-Obese |
7.889500E-02 |
| Normal-vs-Extreme_Obese |
9.130300E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.938400E-01 |
| Normal_Weight-vs-Obese |
3.605600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.553800E-01 |
| Extreme_Weight-vs-Obese |
4.432100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.718400E-01 |
| Obese-vs-Extreme_Obese |
3.904800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.794000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.036000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.834500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.598200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.652200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.699830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.695240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.010300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.155600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.965800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.703900E-03 |
| Normal-VS-Type2 PRCC |
2.16809999999956E-05 |
| Normal-VS-KIRP CIMP |
2.385200E-01 |
| Normal-VS-Unclassified PRCC |
4.105400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.610300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.205550E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.061000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.625100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.676500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.293970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.1758999997098E-07 |
| Normal-vs-N1 |
6.252200E-01 |
| Normal-vs-N2 |
4.020800E-01 |
| N0-vs-N1 |
3.502400E-02 |
| N0-vs-N2 |
8.881400E-01 |
| N1-vs-N2 |
4.662800E-01 |
|
|
